Precision System Science Co., Ltd. (7707.T)
JPY 191.0
(0.0%)
JPY 191.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.9 Billion JPY | -22.56% |
| 2022 | 2.46 Billion JPY | 5.46% |
| 2021 | 2.33 Billion JPY | 6.02% |
| 2020 | 2.2 Billion JPY | 34.29% |
| 2019 | 1.63 Billion JPY | 18.2% |
| 2018 | 1.38 Billion JPY | -18.27% |
| 2017 | 1.69 Billion JPY | -4.97% |
| 2016 | 1.78 Billion JPY | -16.4% |
| 2015 | 2.13 Billion JPY | -0.54% |
| 2014 | 2.14 Billion JPY | -0.47% |
| 2013 | 2.15 Billion JPY | 42.01% |
| 2012 | 1.51 Billion JPY | 7.96% |
| 2011 | 1.4 Billion JPY | -7.43% |
| 2010 | 1.52 Billion JPY | 8.93% |
| 2009 | 1.39 Billion JPY | 10.12% |
| 2008 | 1.26 Billion JPY | -20.6% |
| 2007 | 1.59 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 1.9 Billion JPY | -22.56% |
| 2023 Q3 | 468.3 Million JPY | 4.04% |
| 2023 Q2 | 450.1 Million JPY | -10.8% |
| 2023 Q1 | 504.61 Million JPY | -18.69% |
| 2023 Q4 | 483.59 Million JPY | 3.26% |
| 2022 Q1 | 648.24 Million JPY | 12.22% |
| 2022 FY | 2.46 Billion JPY | 5.46% |
| 2022 Q4 | 620.64 Million JPY | 6.08% |
| 2022 Q3 | 585.05 Million JPY | -3.82% |
| 2022 Q2 | 608.28 Million JPY | -6.16% |
| 2021 FY | 2.33 Billion JPY | 6.02% |
| 2021 Q1 | 546.77 Million JPY | -9.02% |
| 2021 Q3 | 618.3 Million JPY | 4.44% |
| 2021 Q2 | 591.98 Million JPY | 8.27% |
| 2021 Q4 | 577.64 Million JPY | -6.58% |
| 2020 Q1 | 521.03 Million JPY | 13.88% |
| 2020 FY | 2.2 Billion JPY | 34.29% |
| 2020 Q2 | 540.67 Million JPY | 3.77% |
| 2020 Q3 | 539.39 Million JPY | -0.24% |
| 2020 Q4 | 600.99 Million JPY | 11.42% |
| 2019 Q1 | 388.59 Million JPY | 20.67% |
| 2019 Q2 | 395.7 Million JPY | 1.83% |
| 2019 Q3 | 397.99 Million JPY | 0.58% |
| 2019 Q4 | 457.54 Million JPY | 14.96% |
| 2019 FY | 1.63 Billion JPY | 18.2% |
| 2018 FY | 1.38 Billion JPY | -18.27% |
| 2018 Q3 | 350.15 Million JPY | -6.93% |
| 2018 Q2 | 376.2 Million JPY | 11.01% |
| 2018 Q1 | 338.89 Million JPY | -22.41% |
| 2018 Q4 | 322.04 Million JPY | -8.03% |
| 2017 Q1 | 409.97 Million JPY | -7.17% |
| 2017 Q4 | 436.77 Million JPY | 6.13% |
| 2017 Q3 | 411.56 Million JPY | -6.25% |
| 2017 Q2 | 439.01 Million JPY | 7.08% |
| 2017 FY | 1.69 Billion JPY | -4.97% |
| 2016 Q1 | 427.45 Million JPY | -26.74% |
| 2016 FY | 1.78 Billion JPY | -16.4% |
| 2016 Q3 | 466.85 Million JPY | 3.73% |
| 2016 Q4 | 441.63 Million JPY | -5.4% |
| 2016 Q2 | 450.08 Million JPY | 5.29% |
| 2015 Q2 | 525.88 Million JPY | -0.71% |
| 2015 FY | 2.13 Billion JPY | -0.54% |
| 2015 Q4 | 583.47 Million JPY | 17.32% |
| 2015 Q3 | 497.35 Million JPY | -5.42% |
| 2015 Q1 | 529.63 Million JPY | -3.44% |
| 2014 Q2 | 559.62 Million JPY | -1.56% |
| 2014 Q3 | 471.32 Million JPY | -15.78% |
| 2014 Q4 | 548.53 Million JPY | 16.38% |
| 2014 FY | 2.14 Billion JPY | -0.47% |
| 2014 Q1 | 568.47 Million JPY | -17.68% |
| 2013 Q2 | 469.32 Million JPY | 6.24% |
| 2013 Q4 | 690.55 Million JPY | 24.09% |
| 2013 FY | 2.15 Billion JPY | 42.01% |
| 2013 Q3 | 556.5 Million JPY | 18.58% |
| 2013 Q1 | 441.75 Million JPY | 8.65% |
| 2012 Q2 | 370.35 Million JPY | 2.73% |
| 2012 Q3 | 382.24 Million JPY | 3.21% |
| 2012 Q4 | 406.59 Million JPY | 6.37% |
| 2012 FY | 1.51 Billion JPY | 7.96% |
| 2012 Q1 | 360.49 Million JPY | 2.6% |
| 2011 FY | 1.4 Billion JPY | -7.43% |
| 2011 Q2 | 360.15 Million JPY | 6.11% |
| 2011 Q3 | 356.65 Million JPY | -0.97% |
| 2011 Q4 | 351.37 Million JPY | -1.48% |
| 2011 Q1 | 339.41 Million JPY | -24.88% |
| 2010 Q2 | 339.57 Million JPY | -5.02% |
| 2010 Q1 | 357.5 Million JPY | -10.23% |
| 2010 FY | 1.52 Billion JPY | 8.93% |
| 2010 Q3 | 372.58 Million JPY | 9.72% |
| 2010 Q4 | 451.85 Million JPY | 21.28% |
| 2009 Q2 | 330.03 Million JPY | 3.6% |
| 2009 FY | 1.39 Billion JPY | 10.12% |
| 2009 Q4 | 398.26 Million JPY | 14.09% |
| 2009 Q3 | 349.08 Million JPY | 5.77% |
| 2009 Q1 | 318.55 Million JPY | -10.02% |
| 2008 Q1 | 322.47 Million JPY | 0.0% |
| 2008 FY | 1.26 Billion JPY | -20.6% |
| 2008 Q4 | 354.04 Million JPY | 21.29% |
| 2008 Q3 | 291.89 Million JPY | -3.15% |
| 2008 Q2 | 301.37 Million JPY | -6.54% |
| 2007 FY | 1.59 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 9.85 Billion JPY | 80.661% |
| DNA Chip Research Inc. | 324.19 Million JPY | -488.108% |
| Cosmo Bio Company,Limited | 2.73 Billion JPY | 30.186% |
| H.U. Group Holdings, Inc. | 67.27 Billion JPY | 97.166% |
| FALCO HOLDINGS Co., Ltd. | 10.77 Billion JPY | 82.299% |
| BML, Inc. | 36.46 Billion JPY | 94.771% |
| Human Metabolome Technologies, Inc. | 639.4 Million JPY | -198.188% |